ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $117,000 | -38.1% | 54,095 | 0.0% | 0.00% | – |
Q2 2021 | $189,000 | -96.7% | 54,095 | -90.7% | 0.00% | -100.0% |
Q1 2021 | $5,708,000 | -68.2% | 578,926 | -65.1% | 0.00% | -50.0% |
Q4 2020 | $17,967,000 | +65.3% | 1,657,433 | +57.1% | 0.00% | +100.0% |
Q3 2020 | $10,868,000 | -75.5% | 1,055,133 | -50.3% | 0.00% | -83.3% |
Q2 2020 | $44,363,000 | +85.1% | 2,124,648 | -13.4% | 0.01% | +50.0% |
Q1 2020 | $23,969,000 | +66.2% | 2,453,366 | +96.0% | 0.00% | +100.0% |
Q4 2019 | $14,421,000 | +153.0% | 1,251,787 | +19.7% | 0.00% | +100.0% |
Q3 2019 | $5,701,000 | -14.1% | 1,046,102 | +87.5% | 0.00% | 0.0% |
Q2 2019 | $6,635,000 | – | 558,036 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,043,212 | $46,578,000 | 47.83% |
Soleus Capital Management, L.P. | 342,800 | $3,949,000 | 3.81% |
ACUTA CAPITAL PARTNERS, LLC | 1,322,500 | $15,235,000 | 3.77% |
RTW INVESTMENTS, LP | 6,386,607 | $73,574,000 | 2.78% |
Ghost Tree Capital, LLC | 1,175,000 | $13,536,000 | 2.58% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $5,530,000 | 2.48% |
VHCP Management III, LLC | 946,234 | $10,901,000 | 2.16% |
Avoro Capital Advisors LLC | 5,250,000 | $60,480,000 | 1.78% |
VHCP Management II, LLC | 383,620 | $4,419,000 | 1.16% |
Rhenman & Partners Asset Management AB | 650,000 | $7,488,000 | 0.82% |